CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475231247
- Phone
- 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- 4 Open-market sale Former 10% Owner sold 30,000 shares at $6.16 ($184,800)
- 425 Deal Prospectus/Communication re Business Combination
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 425 Deal Prospectus/Communication re Business Combination
- 4 Open-market buy 10% owner bought 329,153 shares at an average $4.93 ($1,624,121)
- 4 Open-market buy 10% owner bought 17,608 shares at an average $4.98 ($87,713)
- 3 Insider Initial Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Exit or restructuring costs · Change in control · Executive or director change · Regulation FD disclosure · Other events
- 8-K Event Executive or director change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 2 of 20 · 400 filings